Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases
A phase 2 trial of Gamma Knife in Brain metastases, run by University of Alabama at Birmingham, completed.
Overview
Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases is a phase 2 interventional study registered as NCT00582075 by University of Alabama at Birmingham, with 25 participants recorded, started 2002-07 and reaching its primary completion in 2008-10. Interventions recorded: temozolomide. Conditions recorded: Cancer, Brain Metastases.
Linked to the technology Gamma Knife because the registry's title names it ("gamma knife") and Brain metastases among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialStudy of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma
Shares Gamma Knife and the tag pipeline.
- TrialMulticenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma
Shares Gamma Knife and the tag pipeline.
- TrialNBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma
Shares Temozolomide and the tag pipeline.
- TrialA Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma
Shares Temozolomide and the tag pipeline.
- TrialA Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
Shares Temozolomide and the tag pipeline.
- TrialA Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
Shares Temozolomide and the tag pipeline.
- TrialA Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
Shares Temozolomide and the tag pipeline.
- TrialA Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma
Shares Temozolomide and the tag pipeline.